Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations

1. FlynnJL

2004

Immunology of tuberculosis and implications in vaccine development.

Tuberculosis (Edinb)

84

93

101

2. KaufmannSHBaumannSNasser EddineA

2006

Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.

Int J Tuberc Lung Dis

10

1068

1079

3. MartinC

2006

Tuberculosis vaccines: Past, present and future.

Curr Opin Pulm Med

12

186

191

4. SkeikyYASadoffJC

2006

Advances in tuberculosis vaccine strategies.

Nat Rev Microbiol

4

469

476

5. LauvauGPamerEG

2001

CD8 T cell detection of bacterial infection: Sniffing for formyl peptides derived from Mycobacterium tuberculosis.

J Exp Med

193

F35

F39

6. MiguelesSALaboricoACShupertWLSabbaghianMSRabinR

2002

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.

Nat Immunol

3

1061

1068

7. SallustoFLenigDForsterRLippMLanzavecchiaA

1999

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Nature

401

708

712

8. DisisMLdela RosaCGoodellVKuanLYChangJC

2006

Maximizing the retention of antigen specific lymphocyte function after cryopreservation.

J Immunol Methods

308

13

18

9. HortonHThomasEPStuckyJAFrankIMoodieZ

2007

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.

J Immunol Methods

323

39

54

10. MaeckerHTMoonJBhatiaSGhanekarSAMainoVC

2005

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.

BMC Immunol

6

17

11. MittruckerHWSteinhoffUKohlerAKrauseMLazarD

2007

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.

Proc Natl Acad Sci U S A

104

12434

12439